Charles Lin, M.D.
Dr. Charles Lin is a board-certified ophthalmologist and fellowship-trained cornea specialist. He spearheads the cornea transplant program at Stanford University and has launched cutting edge surgical procedures including ultra-thin DSAEK, DMEK, DSO, and DALK at Stanford. He leads clinical trials at Stanford focusing on cornea transplantation and ocular inflammation and infections. Dr. Lin received his AB in Environmental Science and Public Policy from Harvard University, graduating summa cum laude. He attended medical school at the University of California, San Francisco, where he received his M.D. with honors. He completed his ophthalmology residency at the University of California, San Francisco and Cornea, External Disease, and Refractive Surgery fellowship at the F.I. Proctor Foundation and University of California, San Francisco.
Financial relationships
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.